Pharmacology- Autonomic drugs Flashcards
Acetylcholine receptors
Nicotinic
Nicotinic ACh receptors are ligand-gated Na+/K+ channels.
Two subtypes: NN (found in autonomic ganglia, adrenal medulla) and NM (found in neuromuscular junction of skeletal muscle).
Acetylcholine receptors
Muscarinic
Muscarinic ACh receptors are G-protein–coupled receptors that usually act through 2nd messengers.
5 subtypes: M1–5 found in heart, smooth muscle, brain, exocrine glands, and on sweat glands (cholinergic sympathetic).
G-protein–linked second messengers
α1 (Q)
α2 (i)
β1 (s)
vascular smooth muscle contraction, mydriasis, Increase intestinal and bladder sphincter muscle contraction.
Decrease sympathetic (adrenergic) outflow, Decrease insulin release, Decrease lipolysis, Increase platelet aggregation, Decrease aqueous humor production.
Increase: heart rate, contractility, renin release, lipolysis.
G-protein–linked second messengers
β2 (s)
β3 (s)
Vasodilation, bronchodilation (two lungs), Increase lipolysis, Increase insulin release, Increase glycogenolysis, decrease uterine tone (tocolysis),
Increase aqueous humor production, Increase cellular K+ uptake.
Increase: lipolysis, thermogenesis in skeletal muscle, bladder relaxation.
G-protein–linked second messengers
M1 (Q)
M2 (i)
M3 (Q)
Mediates higher cognitive functions, stimulates enteric nervous system
Decrease heart rate and contractility of atria
Increase: exocrine gland secretions, gut peristalsis, bladder contraction, bronchoconstriction, miosis, accommodation, insulin release.
G-protein–linked second messengers
D1 (s)
D2 (i)
Relaxes renal vascular smooth muscle, activates direct pathway of striatum.
Modulates transmitter release, especially in brain, inhibits indirect pathway of striatum
G-protein–linked second messengers
H1 (q)
H2 (s)
Increase: nasal and bronchial mucus production, vascular permeability, bronchoconstriction, pruritus, pain.
Gastric acid secretion
G-protein–linked second messengers
V1 (Q)
V2 (s)
vascular smooth muscle contraction
H2O permeability and reabsorption via upregulating aquaporin-2 in collecting twobules (tubules) of kidney.
“After QISSeS (kisses), you get a QIQ(kick) out of SIQ(sick) SQS(super qinky sex).”
pag. 234
Release of norepinephrine from a sympathetic nerve ending
is modulated by NE itself, acting on presynaptic α2-autoreceptors, negative feedback.
Autonomic drugs
Pag. 235
Cholinomimetic agents
Direct agents
Bethanechol
Carbachol
Methacholine
Pilocarpine
Bethanechol
- Action
- Applications
Activates bowel and bladder smooth muscle; resistant to AChE. No nicotinic activity.
Postoperative ileus, neurogenic ileus, urinary
retention
Carbachol
- Action
- Applications
Carbon copy of acetylcholine (but resistant to AChE).
Constricts pupil and relieves intraocular pressure in open-angle glaucoma.
Methacholine
- Action
- Applications
Stimulates muscarinic receptors in airway when inhaled.
Challenge test for diagnosis of asthma
Pilocarpine
- Action
- Applications
Contracts ciliary muscle of eye (open-angle glaucoma), pupillary sphincter (closed-angle glaucoma); resistant to AChE, can cross bloodbrain barrier (tertiary amine).
Potent stimulator of sweat, tears, and saliva. Open-angle and closed-angle glaucoma, xerostomia (Sjögren syndrome).
Cholinomimetic agents Indirect agonists (anticholinesterases)
Donepezil, rivastigmine, galantamine Edrophonium Neostigmine Physostigmine Pyridostigmine
Donepezil, rivastigmine, galantamine
- Clinical use
DONa RIVA dances at the GALA: alzheimer
Edrophonium
- Clinical use
Historically used to diagnose myasthenia gravis; replaced by anti-AChR Ab (anti-acetylcholine receptor antibody) test.
Neostigmine
- Clinical use
Postoperative and neurogenic ileus and urinary retention, myasthenia gravis, reversal of neuromuscular junction blockade (postoperative).
- No CNS penetration (quaternary amine)